Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

RANKL/TNFSF11, Cynomolgus (HEK293, Fc)

Selected Variant

HY-P75999-01

Size: 2 µg

RANKL (TNFSF11), a type II transmembrane protein, is a receptor activator of NF-κB (RANK) ligand. RANKL is an activator of RANK. When binding to RANK, it induces the differentiation of monocyte/macrophage-lineage cells into osteoclasts and leads to osteoclast precursor maturation. RANKL is critical for osteoclasts maturation, bone modeling, and bone remodeling, as well as the development of lymph nodes (LNs) . RANKL/TNFSF11 Protein, Human (HEK293, hFc) is a recombinant human RANKL (G63-D244) with N-terminal hFc tag, which is produced in HEK293[1][2].

Product Specifications

Product Name Alternative

RANKL/TNFSF11 Protein, Cynomolgus (HEK293, Fc), Cynomolgus, HEK293

UNSPSC

12352202

Type

Recombinant Proteins

Assay Protocol

https://www.medchemexpress.com/cytokines/rankl-protein-cynomolgus-hek293-fc.html

Purity

97.00

Smiles

GSQHIRAEKAMVDGSWLDLAKRSKLEAQPFAHLTINATNIPTGSHKVSLSSWYHDRGWAKISNMTFSNGKLIVNQDGFYYLYANICFRHHETSGDLATEYLQLMVYVTKTSIKIPSSHTLMKGGSTKYWSGNSEFHFYSINVGGFFKLRSGEEISVEVSNPSLLDPDQDATYFGAFKVRDID

Molecular Formula

/ (Gene_ID) A0A7N9DBU4 (G136-D317) (Accession)

Molecular Weight

Approximately 56 kDa, based on SDS-PAGE under reducing conditions.

References & Citations

[1]Ono T, et al. RANKL biology: bone metabolism, the immune system, and beyond. Inflamm Regen. 2020 Feb 7;40:2.|[2]Li B, et al. Roles of the RANKL-RANK Axis in Immunity-Implications for Pathogenesis and Treatment of Bone Metastasis. Front Immunol. 2022 Mar 21;13:824117.|[3]Tobeiha M, et al. RANKL/RANK/OPG Pathway: A Mechanism Involved in Exercise-Induced Bone Remodeling. Biomed Res Int. 2020 Feb 19;2020:6910312.|[4]Mikami S, et al. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas. J Pathol. 2009 Aug;218 (4) :530-9.|[5]Peng X, et al. Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer. PLoS One. 2013;8 (3) :e58361.|[6]Lloyd SA, et al. Soluble RANKL induces high bone turnover and decreases bone volume, density, and strength in mice. Calcif Tissue Int. 2008 May;82 (5) :361-72.

Shipping Conditions

Room temperature in continental US; may vary elsewhere.

Storage Conditions

Stored at -20°C for 2 years

Scientific Category

Recombinant Proteins

Available Sizes

Price

Sign In for Pricing

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD106 / VCAM1 (VCAM1/843), CF640R conjugate, 0.1mg/mL
BNC400843-100 1x 100 µL

CD106 / VCAM1 (VCAM1/843), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Anti-STIM1 Antibody Picoband® (Dylight488 Conjugate)
PB9406-Dylight488 100 µg

Anti-STIM1 Antibody Picoband® (Dylight488 Conjugate)

Sign In for Pricing
View Details
Anti-TrkA/NTRK1 Antibody Picoband® (Dylight488 Conjugate)
PA2149-1-Dylight488 100 µg

Anti-TrkA/NTRK1 Antibody Picoband® (Dylight488 Conjugate)

Sign In for Pricing
View Details
C-Myc (MYC275), CF405S conjugate, 0.1mg/mL
BNC040275-500 1x 500 µL

C-Myc (MYC275), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
HCG-alpha (HCGa/53), CF740 conjugate, 0.1mg/mL
BNC740053-500 1x 500 µL

HCG-alpha (HCGa/53), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details